G
Genprex D
D
GNPX
0.27250
USD
-0.01
(-4.42%)
مغلق
حجم التداول
7,358
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
9,119,699
الأخبار المقالات
العنوان: Genprex
القطاع: Healthcare
الصناعة: Biotechnology
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for largepatient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.